Cubist Systematic Strategies LLC Acquires 7,483 Shares of Plexus Corp. (NASDAQ:PLXS)

Cubist Systematic Strategies LLC boosted its stake in Plexus Corp. (NASDAQ:PLXS - Free Report) by 25.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 37,259 shares of the technology company's stock after purchasing an additional 7,483 shares during the quarter. Cubist Systematic Strategies LLC owned approximately 0.14% of Plexus worth $5,830,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently modified their holdings of the company. Blue Trust Inc. increased its stake in Plexus by 12.1% in the 4th quarter. Blue Trust Inc. now owns 776 shares of the technology company's stock worth $121,000 after purchasing an additional 84 shares during the period. Nomura Asset Management Co. Ltd. increased its stake in Plexus by 45.5% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 320 shares of the technology company's stock worth $50,000 after purchasing an additional 100 shares during the period. Tocqueville Asset Management L.P. increased its stake in Plexus by 1.8% in the 4th quarter. Tocqueville Asset Management L.P. now owns 5,907 shares of the technology company's stock worth $924,000 after purchasing an additional 107 shares during the period. GAMMA Investing LLC increased its stake in Plexus by 17.2% in the 4th quarter. GAMMA Investing LLC now owns 891 shares of the technology company's stock worth $139,000 after purchasing an additional 131 shares during the period. Finally, Aquatic Capital Management LLC increased its stake in Plexus by 134.0% in the 4th quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company's stock worth $37,000 after purchasing an additional 134 shares during the period. Institutional investors own 94.45% of the company's stock.

Plexus Trading Up 1.5%

Shares of NASDAQ PLXS traded up $1.99 during midday trading on Tuesday, hitting $133.35. 144,607 shares of the company traded hands, compared to its average volume of 167,103. Plexus Corp. has a 12-month low of $100.96 and a 12-month high of $172.89. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.70 and a current ratio of 1.53. The stock has a 50-day moving average price of $124.11 and a 200 day moving average price of $143.34. The firm has a market cap of $3.61 billion, a P/E ratio of 30.94 and a beta of 0.80.

Plexus (NASDAQ:PLXS - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The technology company reported $1.66 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.12. The company had revenue of $980.17 million for the quarter, compared to analysts' expectations of $980.07 million. Plexus had a return on equity of 10.36% and a net margin of 3.03%. The firm's revenue for the quarter was up 1.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.94 earnings per share. As a group, analysts expect that Plexus Corp. will post 5.9 earnings per share for the current year.

Insider Buying and Selling

In other Plexus news, CEO Todd P. Kelsey sold 2,000 shares of the business's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $140.00, for a total value of $280,000.00. Following the sale, the chief executive officer now directly owns 87,665 shares of the company's stock, valued at approximately $12,273,100. The trade was a 2.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michael J. Running sold 1,250 shares of the business's stock in a transaction on Friday, February 21st. The stock was sold at an average price of $138.62, for a total value of $173,275.00. Following the completion of the sale, the insider now directly owns 1,276 shares in the company, valued at $176,879.12. This trade represents a 49.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,137 shares of company stock valued at $577,916 over the last ninety days. Company insiders own 1.76% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on PLXS. Benchmark decreased their price target on Plexus from $170.00 to $160.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Needham & Company LLC reaffirmed a "buy" rating and issued a $162.00 price target (down previously from $172.00) on shares of Plexus in a research note on Friday, April 25th. Finally, Stifel Nicolaus set a $145.00 price objective on shares of Plexus in a research report on Thursday, April 24th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $155.67.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.